Invetx *

Invetx was a Boston-based veterinary biotechnology company developing protein-based therapeutics — species-specific, half-life-extended monoclonal antibodies (mAbs) — for chronic conditions in companion animals (dogs and cats). Its integrated platform spanned antibody discovery, optimization, Fc-variant half-life extension, development and manufacturing, with lead program IVX-01. Backed by GV, F-Prime Capital, Novo Holdings, Eight Roads, Anterra Capital, Casdin Capital and Tekla, Invetx was acquired by Dechra Pharmaceuticals in July 2024 for up to $520M. It exposes no public API, developer, or documentation surface, and its standalone website (invetx.com) has been decommissioned since the acquisition; this profile is retained as a network lead / portfolio record.

Invetx * is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Animal Health, and Veterinary.

📡 Profile data on GitHub

0 APIs

Company Life Sciences Biotechnology Animal Health Veterinary Monoclonal Antibodies Therapeutics Acquired

Markets this provider is in provisional

The Kin Score Market layer reads a provider inside its market: its position, and how deep its integrations go. Depth is only comparable within a position. Provisional and unweighted: not part of the Kin Score or agent readiness.

Market	Position	Depth	Registered MCP server	Declares compatibility
Veterinary & Pet Care	undeclared	-	-	-

Registered MCP server and declares compatibility are report only — not weighted. Undeclared means we found nothing we can read, so there is no number: we never infer integrations.

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Invetx Domain Security

DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Source (apis.yml)

aid: invetx
deliveryModel:
  model: unknown
  open_source: false
  commercial: false
  callable_host: false
  label: Delivery model not determined — needs a product licence on record
  confidence: low
  source:
  - none
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source:
  - security
  generated: '2026-11-06'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/invetx.png
name: Invetx *
description: Invetx was a Boston-based veterinary biotechnology company developing protein-based therapeutics — species-specific,
  half-life-extended monoclonal antibodies (mAbs) — for chronic conditions in companion animals (dogs and cats). Its integrated
  platform spanned antibody discovery, optimization, Fc-variant half-life extension, development and manufacturing, with lead
  program IVX-01. Backed by GV, F-Prime Capital, Novo Holdings, Eight Roads, Anterra Capital, Casdin Capital and Tekla, Invetx
  was acquired by Dechra Pharmaceuticals in July 2024 for up to $520M. It exposes no public API, developer, or documentation
  surface, and its standalone website (invetx.com) has been decommissioned since the acquisition; this profile is retained
  as a network lead / portfolio record.
url: https://raw.githubusercontent.com/api-evangelist/invetx/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
x-status: acquired
x-acquired-by: dechra
x-acquired-date: '2024-07-18'
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Life Sciences
- Biotechnology
- Animal Health
- Veterinary
- Monoclonal Antibodies
- Therapeutics
- Acquired
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/invetx-domain-security.yml
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this

find_providersBrowse and filter every provider in the catalog.
get_provider_artifactsEvery artifact this provider publishes, grouped by type.
get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
get_provider_ratingPRO — composite, band, trend and facet scores.
apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
resolveTurn a domain, URL or GitHub org into the provider it belongs to.
find_cohortsEvery scored population of providers in the catalog.

All 92 tools →

Call it yourself

curl for this page

This provider

curl "https://apis.io/api/v1/providers/invetx"

All providers

curl "https://apis.io/api/v1/providers?limit=25"

Every operation they expose

curl "https://apis.io/api/v1/providers/invetx/operations?limit=25"

How their score was established

curl "https://apis.io/api/v1/providers/invetx/evidence"

Calls without X-API-Key need no key. Calls with it need a paid plan — get a key.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

GitHub Google LinkedIn

A second provider on the same verified email joins the account you already have.